Increased viability of PC12 cells exposed to amyloid-β peptide by transduction with human TAT-methionine sulfoxide reductase

被引：13

作者：

Jung, B

Lee, EH

Chung, WS

Lee, SJ

Shin, SH

Joo, SH

Kim, SK

Lee, JH ^{[1
]}

机构：

[1] Kyung Hee Univ, Grad Sch EW Med Sci, Yongin, South Korea

[2] Yonsei Univ, Coll Med, Inst Vis Res, Dept Ophthalmol, Seoul 120752, South Korea

[3] Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea

[4] Yonsei Univ, Brain Korea Project Med Sci 21, Seoul 120749, South Korea

来源：

NEUROREPORT | 2003年 / 14卷 / 18期

关键词：

Alzheimer's disease; amyloid-beta; methionine sulfoxide reductase; MsrA transduction; TAT-MsrA;

D O I：

10.1097/00001756-200312190-00012

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Methionine sulfoxide reductase (MsrA) catalyzes the reduction of methionine sulfoxide to methionine, which is able to scavenge oxidatively damaged proteins. Oxidative stress has been linked to the pathophysiology of Alzheimer's disease, and a decrease in MsrA activity has also been implicated in Alzheimer's disease. The transactivator of transcription (TAT) protein from human immunodeficiency virus I has been used to deliver full-length proteins into mammalian cells. We produced genetic in-frame TAT-MsrA fusion protein and successfully transduced it into PCl2 cells, where it showed enzymatic activity. We showed that transduction of TAT-MsrA increased cell viability and reduced DNA fragmentation in PCl2 cells treated with amyloid-beta (Abeta). We suggest that MsrA transduction could reduce the oxidative damage caused to cellular proteins by Abeta and could play a role in the treatment of Alzheimer's disease. (C) 2003 Lippincott Williams Wilkins.

引用

页码：2349 / 2353

页数：5

共 25 条

[1] Protection against ischemic brain injury by protein therapeutics
Asoh, S
Ohsawa, I
Mori, T
Hiraide, T
Katayama, Y
Kimura, M
Ozaki, D
Yamagata, K
Ohta, S
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (26) : 17107 - 17112
[2] VITAMIN-E PROTECTS NERVE-CELLS FROM AMYLOID BETA-PROTEIN TOXICITY
BEHL, C
DAVIS, J
COLE, GM
SCHUBERT, D
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 186 (02) : 944 - 950
[3] HYDROGEN-PEROXIDE MEDIATES AMYLOID-BETA PROTEIN TOXICITY
BEHL, C
DAVIS, JB
LESLEY, R
SCHUBERT, D
[J]. CELL, 1994, 77 (06) : 817 - 827
[4] Cao GD, 2002, J NEUROSCI, V22, P5423
[5] Inhibition of neuronal apoptosis in vitro and in vivo using TAT-Mediated protein transduction
Dietz, GPH
Kilic, E
Bähr, M
[J]. MOLECULAR AND CELLULAR NEUROSCIENCE, 2002, 21 (01) : 29 - 37
[6] Intercellular trafficking and protein delivery by a herpesvirus structural protein
Elliott, G
OHare, P
[J]. CELL, 1997, 88 (02) : 223 - 233
[7] Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb
Ezhevsky, SA
Nagahara, H
VoceroAkbani, AM
Gius, DR
Wei, MC
Dowdy, SF
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) : 10699 - 10704
[8] Decrease in peptide methionine sulfoxide reductase in Alzheimer's disease brain
Gabbita, SP
Aksenov, MY
Lovell, MA
Markesbery, WR
[J]. JOURNAL OF NEUROCHEMISTRY, 1999, 73 (04) : 1660 - 1666
[9] Increased nuclear DNA oxidation in the brain in Alzheimer's disease
Gabbita, SP
Lovell, MA
Markesbery, WR
[J]. JOURNAL OF NEUROCHEMISTRY, 1998, 71 (05) : 2034 - 2040
[10] Aging renders the brain vulnerable to amyloid β-protein neurotoxicity
Geula, C
Wu, CK
Saroff, D
Lorenzo, A
Yuan, ML
Yankner, BA
[J]. NATURE MEDICINE, 1998, 4 (07) : 827 - 831

← 1 2 3 →